Sellas Life Valuation
| SLS Stock | USD 3.97 0.20 5.31% |
At this time, the company appears to be undervalued. Sellas Life Sciences has a current Real Value of $4.92 per share. The regular price of the company is $3.97. Our model measures the value of Sellas Life Sciences from inspecting the company fundamentals such as Shares Owned By Institutions of 20.82 %, return on equity of -0.84, and Shares Outstanding of 170.28 M as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 14.5167 | Enterprise Value | Enterprise Value Ebitda (1.71) | Price Sales 26.8951 | Enterprise Value Revenue 20.8445 |
Undervalued
Today
Please note that Sellas Life's price fluctuation is risky at this time. Calculation of the real value of Sellas Life Sciences is based on 3 months time horizon. Increasing Sellas Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Sellas stock is determined by what a typical buyer is willing to pay for full or partial control of Sellas Life Sciences. Since Sellas Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Sellas Stock. However, Sellas Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.97 | Real 4.92 | Target 6.83 | Hype 3.96 | Naive 3.72 |
The intrinsic value of Sellas Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Sellas Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Sellas Life Sciences helps investors to forecast how Sellas stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Sellas Life more accurately as focusing exclusively on Sellas Life's fundamentals will not take into account other important factors: Sellas Life Cash |
|
Sellas Life Total Value Analysis
Sellas Life Sciences is at this time expected to have company total value of 618.68 M with market capitalization of 641.96 M, debt of 1 M, and cash on hands of 26.99 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Sellas Life fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
618.68 M | 641.96 M | 1 M | 26.99 M |
Sellas Life Asset Utilization
One of the ways to look at asset utilization of Sellas is to check how much profit was generated for every dollar of assets it reports. Sellas Life Sciences has a negative utilization of assets of -0.45 %, losing $0.00449 for each dollar of assets held by the company. Inadequate asset utilization indicates the company is being less effective with each dollar of assets it has. In other words, asset utilization of Sellas Life Sciences shows how discouraging it operates for each dollar spent on its assets.Sellas Life Profitability Analysis
Based on the measurements of profitability obtained from Sellas Life's financial statements, Sellas Life Sciences may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in March. Profitability indicators assess Sellas Life's ability to earn profits and add value for shareholders.Net Loss | First Reported 2006-12-31 | Previous Quarter -6.6 M | Current Value -6.8 M | Quarterly Volatility 7 M |
For Sellas Life profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Sellas Life Sciences to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Sellas Life utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Sellas Life's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Sellas Life over time as well as its relative position and ranking within its peers.
Sellas Life Earnings per Share Projection vs Actual
The next projected EPS of Sellas Life is estimated to be -0.079175 with future projections ranging from a low of -0.095 to a high of -0.05. Sellas Life's most recent 12-month trailing earnings per share (EPS TTM) is at -0.27. Please be aware that the consensus of earnings estimates for Sellas Life Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Sellas Life Earnings Estimation Breakdown
The calculation of Sellas Life's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Sellas Life is estimated to be -0.079175 with the future projection ranging from a low of -0.095 to a high of -0.05. Please be aware that this consensus of annual earnings estimates for Sellas Life Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.1 Lowest | Expected EPS | -0.05 Highest |
Sellas Life Earnings Projection Consensus
Suppose the current estimates of Sellas Life's value are higher than the current market price of the Sellas Life stock. In this case, investors may conclude that Sellas Life is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Sellas Life's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 3 | 44.54% | 0.0 | -0.079175 | -0.27 |
Sellas Life Ownership Allocation
Sellas Life Sciences shows a total of 170.28 Million outstanding shares. About 78.54 % of Sellas Life outstanding shares are held by general public with 0.64 (%) owned by insiders and only 20.82 % by institutional holders. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Sellas Life Profitability Analysis
Reported Net Loss for the year was (30.88 M) with profit before taxes, overhead, and interest of 900 K.About Sellas Life Valuation
The stock valuation mechanism determines Sellas Life's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Sellas Life Sciences based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sellas Life. We calculate exposure to Sellas Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Sellas Life's related companies.| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (47.50) | (45.12) | |
| Operating Profit Margin | (48.24) | (45.83) | |
| Net Loss | (47.50) | (45.12) | |
| Gross Profit Margin | 0.81 | 0.56 |
Sellas Life Current Valuation Indicators
Sellas Life's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Sellas Life's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Sellas Life, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Sellas Life's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Sellas Life's worth.Additional Tools for Sellas Stock Analysis
When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.